{
    "Trade/Device Name(s)": [
        "INNOVANCE D-Dimer",
        "INNOVANCE D-Dimer Controls",
        "INNOVANCE D-Dimer Control 1",
        "INNOVANCE D-Dimer Control 2"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Products GmbH",
    "510(k) Number": "K081732",
    "Predicate Device Reference 510(k) Number(s)": [
        "K063356",
        "K992956"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DAP"
    ],
    "Summary Letter Date": "October 16, 2008",
    "Summary Letter Received Date": "October 17, 2008",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7320"
    ],
    "Regulation Name(s)": [
        "Fibrinogen/Fibrin Degradation Products Assay"
    ],
    "Analyte Class(es)": [
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "D-dimer",
        "cross-linked fibrin degradation products"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Siemens Coagulation Systems",
        "Sysmex Coagulation Systems",
        "Dade Behring Coagulation Systems",
        "BCS Systems"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric detection",
        "Immunoassay with monoclonal antibody-coated particles"
    ],
    "Methodologies": [
        "Quantitative immunoturbidimetric assay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for INNOVANCE D-Dimer assay and controls for quantifying D-dimer in plasma as aid in diagnosing venous thromboembolism on coagulation analyzers",
    "Indications for Use Summary": "Quantitative determination of cross-linked fibrin degradation products (D-dimers) in human plasma as an aid in diagnosis of venous thromboembolism (VTE), and intralaboratory quality control assessment on Siemens and Sysmex Coagulation Systems",
    "fda_folder": "Hematology"
}